Long-term Safety and Clinical Activity of ALN-AS1 in Patients with Acute Intermittent Porphyria (AIP), a rare metabolic disorder. Long-term Safety and Clinical Activity of ALN-AS1 inPatients with Acute Intermittent Porphyria (AIP) ...
A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Clinical Activity of Subcutaneously Administered ALN-AS1 in Patients with Acute Intermittent Porphyria who have Completed a Previous Clinical Study with ALN-AS1 A Multicenter, Open-label Extension Study to Evaluate the Long-term Safety and Clinical Activity of ...
Product Name: Givosiran Product Code: ALN-AS1 INN or Proposed INN: ALN-60519 Other descriptive name: CAS#inD.3.9.1forSodiumSalt.CASnumber1639325-43-1(ParentAcid)Product Name: Givosiran Product Code: ALN-AS1 INN or Proposed INN: ALN-60519 Other descriptive name: CA ...